CME Group’s (CME) “Sell” Rating Reaffirmed at Rosenblatt Securities

CME Group (NASDAQ:CMEGet Free Report)‘s stock had its “sell” rating restated by analysts at Rosenblatt Securities in a research report issued on Thursday, Benzinga reports. They presently have a $187.00 price target on the financial services provider’s stock, up from their previous price target of $185.00. Rosenblatt Securities’ target price would suggest a potential downside of 11.35% from the company’s previous close.

A number of other research analysts have also weighed in on the company. Barclays raised their target price on CME Group from $225.00 to $226.00 and gave the company an “equal weight” rating in a report on Monday, April 8th. The Goldman Sachs Group cut CME Group from a “neutral” rating to a “sell” rating and set a $195.00 price objective on the stock. in a research note on Wednesday, January 3rd. Argus lifted their price objective on shares of CME Group from $225.00 to $245.00 and gave the stock a “buy” rating in a report on Wednesday, March 6th. Keefe, Bruyette & Woods reiterated a “market perform” rating and issued a $229.00 target price on shares of CME Group in a report on Wednesday, April 3rd. Finally, Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $210.00 price target (down from $235.00) on shares of CME Group in a research report on Friday, April 5th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, CME Group presently has a consensus rating of “Hold” and a consensus price target of $217.80.

View Our Latest Stock Analysis on CME

CME Group Price Performance

Shares of CME opened at $210.94 on Thursday. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. The business’s fifty day moving average is $214.73 and its 200 day moving average is $211.90. CME Group has a 12-month low of $175.73 and a 12-month high of $223.80. The stock has a market cap of $75.94 billion, a P/E ratio of 24.00, a P/E/G ratio of 5.97 and a beta of 0.49.

CME Group (NASDAQ:CMEGet Free Report) last posted its earnings results on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share for the quarter, topping analysts’ consensus estimates of $2.44 by $0.06. The company had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.48 billion. CME Group had a net margin of 56.84% and a return on equity of 12.45%. The firm’s revenue was up 3.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.42 EPS. Sell-side analysts anticipate that CME Group will post 9.58 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. OFI Invest Asset Management purchased a new position in shares of CME Group during the 3rd quarter valued at $25,000. Gold Investment Management Ltd. purchased a new stake in CME Group during the fourth quarter valued at about $26,000. Northwest Financial Advisors bought a new position in CME Group during the fourth quarter worth about $28,000. Harbor Investment Advisory LLC increased its stake in shares of CME Group by 966.7% in the fourth quarter. Harbor Investment Advisory LLC now owns 160 shares of the financial services provider’s stock worth $34,000 after purchasing an additional 145 shares in the last quarter. Finally, Compagnie Lombard Odier SCmA bought a new stake in shares of CME Group in the third quarter valued at approximately $37,000. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

About CME Group

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.